FAIR VALUE MEASUREMENTS (Tables)

9 Months Ended

Sep. 30, 2023

Fair Value Disclosures [Abstract]

SCHEDULE OF FINANCIAL INSTRUMENT MEASURED ON RECURRING BASIS

	As of September 30, 2023				Fair Value Measurements
			Fair		As of September 30, 2023
	Amount		Value		Level 1		Level 2		Level 3
Liabilities:
Contingent consideration:
Asuragen (1)	$	610	$	610	$	-	$	-	$	610
Note payable:
BroadOak loan		10,000		11,565		-		-		11,565
	$	10,610	$	12,175	$	-	$	-	$	12,175

(1) See Note 10, Other Accrued Expenses

					Fair Value Measurements
	As of December 31, 2022				As of December 31, 2022
	Amount		Fair Value		Level 1		Level 2		Level 3
Liabilities:
Contingent consideration:
Asuragen (1)	$	1,088	$	1,088	$	-	$	-	$	1,088
Note payable:
BroadOak loan		10,000		11,165		-		-		11,165
	$	11,088	$	12,253	$	-	$	-	$	12,253

(1) See Note 10, Other Accrued Expenses

SCHEDULE OF FAIR VALUE, ASSETS MEASURED ON RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION

A roll forward of the carrying value of the Contingent Consideration Liability and BroadOak Loan to September 30, 2023 is as follows:

										Adjustment
					Transferred			Accretion/		to Fair Value/
	December 31, 2022		Issued		to Accrued Expenses			Interest Accrued		Mark to Market		September 30, 2023
Asuragen	$	1,088	$	-	$	(570	)	$	92	$	-	$	610
BroadOak loans		11,165		-		-			-		400		11,565
	$	12,253	$	-	$	(570	)	$	92	$	400	$	12,175